PLANNED SUCCESSION TO SUPPORT NEXT PHASE OF GROWTH AS COMPANY ADVANCES U.S. PHARMACEUTICAL MANUFACTURING MISSION RICHMOND, Va., May 12, 2026 – Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today...
2026
Phlow Corp. Appoints Dawn Von Rohr as Chief Operating Officer to Advance Domestic Pharmaceutical Manufacturing
RICHMOND, Va., March 18, 2026 – Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Dawn Von Rohr has been appointed Chief Operating Officer (COO). Von Rohr will oversee Phlow’s...
Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP
A Scalable Model for U.S. Pharmaceutical Security LAKE ZURICH, Ill. and RICHMOND, Va., February 9, 2026 – Fresenius Kabi and Phlow Corp. announced today a first-of-its-kind collaboration to onshore the manufacture of Epinephrine Injection, USP, an essential medicine...
Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing
RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active Pharmaceutical Ingredient (API) manufacturing process development in...